Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Meda Pharmaceuticals
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and female patients 12 years of age and older
Must be in generally good health
Must meet minimum symptom requirements, as specified in protocol
Must be willing and able to provide informed consent and participate in all study procedures
2-year history of PAR
Positive skin test to cockroach, dust mite, mold or cat/dog dander
You may not be if
On nasal examination, presence of any nasal mucosal erosion, nasal ulceration or nasal septal perforation at the screening or randomization visit
Nasal diseases likely to affect deposition of intranasal medication, such as sinusitis, rhinitis medicamentosa, significant polyposis or nasal structural abnormalities
Nasal surgery or sinus surgery within the previous year
The use of any investigational drug within 30 days
Presence of any hypersensitivity to drugs similar to azelastine and to either sorbitol or sucralose
Women who are pregnant or nursing
Women of child-bearing potential who are not abstinent and not practicing a medically acceptable method of contraception
Respiratory tract infection within 2 weeks of screening
Respiratory tract infections requiring oral antibiotic treatment within 2 weeks of screening
Patients with asthma with the exception of mild, intermittent
Significant pulmonary disease including COPD
Patients with arrhythmia
Patients with a known history of alcohol or drug abuse
Existence of any surgical or medical condition, which in the opinion of the investigator or sponsor may significantly alter the absorption, distribution, metabolism or excretion of study drug.
Clinically relevant abnormal physical findings within one week of randomization
Overnight abscences from home for more than 3 nights
Employees of the research center or private practice and family members are excluded
Patients who received prohibited medications within specified timepoints in protocol.
Clareo Health | A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies
